ProfileGDS4718 / 206968_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 52% 52% 53% 55% 50% 56% 53% 52% 54% 53% 46% 49% 52% 54% 51% 55% 54% 51% 52% 43% 51% 51% 52% 49% 52% 55% 55% 50% 53% 53% 48% 50% 53% 58% 51% 55% 50% 52% 51% 52% 57% 58% 48% 62% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.6265652
GSM549102patient 115, normal, homogenized [OPG study]5.6284252
GSM549104patient 119, normal, homogenized [OPG study]5.7025353
GSM549108patient 138, normal, homogenized [OPG study]5.8145255
GSM549119patient 077, normal, homogenized [OPG study]5.4996850
GSM549133patient 032, cancer, homogenized [OPG study]5.8099356
GSM549139patient 042, cancer, homogenized [OPG study]5.6978853
GSM549099patient 107, normal, homogenized [OPG study]5.6548452
GSM549109patient 139, normal, homogenized [OPG study]5.7719354
GSM549110patient 046, normal, homogenized [OPG study]5.6803753
GSM549114patient 063, normal, homogenized [OPG study]5.271246
GSM549122patient 082, normal, homogenized [OPG study]5.4517749
GSM549134patient 033, cancer, homogenized [OPG study]5.5916452
GSM549136patient 036, cancer, homogenized [OPG study]5.7235454
GSM549140patient 044, cancer, homogenized [OPG study]5.5680251
GSM549111patient 047, normal, homogenized [OPG study]5.7997855
GSM549113patient 057, normal, homogenized [OPG study]5.6974754
GSM549132patient 031, cancer, homogenized [OPG study]5.5299751
GSM549137patient 038, cancer, homogenized [OPG study]5.6034252
GSM549142patient 047, cancer, homogenized [OPG study]5.2600443
GSM549100patient 110, normal, homogenized [OPG study]5.583651
GSM549107patient 135, normal, homogenized [OPG study]5.5405551
GSM549115patient 068, normal, homogenized [OPG study]5.5831952
GSM549116patient 072, normal, homogenized [OPG study]5.4102149
GSM549120patient 078, normal, homogenized [OPG study]5.6273352
GSM549131patient 030, cancer, homogenized [OPG study]5.7742655
GSM549118patient 074, normal, homogenized [OPG study]5.7778155
GSM549129patient 027, cancer, homogenized [OPG study]5.5322950
GSM549123patient 088, normal, homogenized [OPG study]5.6941553
GSM549124patient 006, cancer, homogenized [OPG study]5.7270753
GSM549126patient 015, cancer, homogenized [OPG study]5.3745148
GSM549128patient 025, cancer, homogenized [OPG study]5.4911250
GSM549103patient 117, normal, homogenized [OPG study]5.7517553
GSM549117patient 073, normal, homogenized [OPG study]5.9255658
GSM549138patient 041, cancer, homogenized [OPG study]5.5857651
GSM549141patient 045, cancer, homogenized [OPG study]5.7867955
GSM549130patient 028, cancer, homogenized [OPG study]5.4941750
GSM549101patient 111, normal, homogenized [OPG study]5.6777952
GSM549105patient 128, normal, homogenized [OPG study]5.6034251
GSM549106patient 134, normal, homogenized [OPG study]5.5794452
GSM549112patient 048, normal, homogenized [OPG study]5.920457
GSM549125patient 011, cancer, homogenized [OPG study]6.0257658
GSM549127patient 024, cancer, homogenized [OPG study]5.3820948
GSM549135patient 035, cancer, homogenized [OPG study]6.2812762